First developed for Canadian patients by WMMC, this Indica-dominant hybrid is rich in the non-psychoactive compound CBG and low in THC. Created by blending a range of strains to achieve a unique cannabinoid profile, it has a fresh, spicy scent with notes of cloves and basil and is designed for patients seeking lower psychoactivity.

CBG is one of the more well-known minor cannabinoids. There is some evidence that CBG may be helpful in reducing pain and inflammation, however, further research to fully examine this in clinical studies is ongoing. 

Please note that this product is partially covered for our veteran clients, meaning that Aurora will apply a 25% discount to the list price, prior to direct billing VAC for a maximum of $8.50 per gram. The remaining balance must be paid via an alternative payment method (e.g. credit card).

Reference: Baron EP. Medicinal Properties of Cannabinoids , Terpenes , and Flavonoids in Cannabis , and Benefits in Migraine , Headache , and Pain : An Update on Current Evidence and Cannabis Science. Headache Curr. 2018;58:1139-1186.